Total Payments
$2,382
2024 Payments
$584.90
Companies
20
Transactions
113
Medicare Patients
903
Medicare Billing
$20,829
Payment Breakdown by Category
Food & Beverage$2,382 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,382 | 113 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $517.93 | 27 | $0 (2024) |
| GlaxoSmithKline, LLC. | $490.29 | 31 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $267.22 | 5 | $0 (2023) |
| Amgen Inc. | $194.77 | 5 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $193.04 | 10 | $0 (2024) |
| OptiNose US, Inc. | $129.67 | 3 | $0 (2022) |
| PFIZER INC. | $124.22 | 6 | $0 (2024) |
| CSL Behring | $72.99 | 4 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $69.62 | 3 | $0 (2024) |
| Blueprint Medicines Corporation | $61.93 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $584.90 | 29 | GENZYME CORPORATION ($209.53) |
| 2023 | $399.31 | 23 | GENZYME CORPORATION ($135.49) |
| 2022 | $923.06 | 36 | Amgen Inc. ($157.01) |
| 2021 | $474.57 | 25 | GlaxoSmithKline, LLC. ($135.26) |
All Payment Transactions
113 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $2.29 | General |
| Category: Immunology | ||||||
| 11/25/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Pharming Healthcare, Inc. | RUCONEST (Biological) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: BIOLOGIC | ||||||
| 10/31/2024 | PFIZER INC. | PANZYGA (Biological), CUTAQUIG | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: IMMUNOLOGY;INFLAMMATION | ||||||
| 10/29/2024 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Immunology | ||||||
| 10/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/07/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: IMMUNOLOGY | ||||||
| 10/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $8.43 | General |
| Category: Immunology | ||||||
| 08/26/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: IMMUNOLOGY | ||||||
| 08/06/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $6.50 | General |
| Category: IMMUNOLOGY | ||||||
| 08/06/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $3.45 | General |
| Category: IMMUNOLOGY | ||||||
| 07/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: RESPIRATORY | ||||||
| 07/30/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $4.86 | General |
| Category: Immunology | ||||||
| 07/25/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: IMMUNOLOGY | ||||||
| 07/02/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: Immunology | ||||||
| 06/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: RESPIRATORY | ||||||
| 05/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $89.11 | General |
| Category: Immunology | ||||||
| 05/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $27.53 | General |
| Category: Immunology | ||||||
| 04/29/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: IMMUNOLOGY | ||||||
| 04/02/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $25.47 | General |
| Category: Immunology | ||||||
| 03/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: Immunology | ||||||
| 02/27/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $31.09 | General |
| Category: RESPIRATORY | ||||||
| 02/27/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $6.40 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 271 | 384 | $26,146 | $6,527 |
| 2022 | 6 | 273 | 504 | $26,978 | $7,482 |
| 2021 | 7 | 218 | 390 | $18,606 | $5,299 |
| 2020 | 5 | 141 | 177 | $7,730 | $1,522 |
Total Patients
903
Total Services
1,455
Medicare Billing
$20,829
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 54 | 61 | $13,094 | $4,134 | 31.6% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 92 | 183 | $6,196 | $924.61 | 14.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 17 | $2,559 | $736.89 | 28.8% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 33 | 36 | $2,817 | $532.05 | 18.9% |
| 95115 | Professional service for single injection of allergen | Office | 2023 | 14 | 20 | $515.00 | $103.19 | 20.0% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2023 | 61 | 67 | $964.75 | $95.81 | 9.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 57 | 70 | $13,230 | $4,906 | 37.1% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 99 | 240 | $7,680 | $1,319 | 17.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 18 | 65 | $2,925 | $559.45 | 19.1% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 29 | 31 | $1,953 | $481.34 | 24.6% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2022 | 56 | 75 | $618.75 | $112.64 | 18.2% |
| 95115 | Professional service for single injection of allergen | Office | 2022 | 14 | 23 | $571.00 | $103.56 | 18.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 44 | 45 | $5,892 | $2,138 | 36.3% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2021 | 76 | 221 | $7,072 | $1,367 | 19.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 15 | 15 | $2,850 | $1,168 | 41.0% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 12 | 26 | $1,170 | $235.47 | 20.1% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 11 | 11 | $693.00 | $204.27 | 29.5% |
| 95115 | Injection of incremental dosages of allergen | Office | 2021 | 12 | 20 | $500.00 | $107.54 | 21.5% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2021 | 48 | 52 | $429.00 | $78.20 | 18.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 24 | 24 | $3,120 | $766.01 | 24.6% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2020 | 73 | 105 | $3,360 | $502.72 | 15.0% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2020 | 11 | 11 | $693.00 | $154.52 | 22.3% |
| 95115 | Injection of incremental dosages of allergen | Office | 2020 | 11 | 15 | $375.00 | $73.31 | 19.5% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2020 | 22 | 22 | $181.50 | $24.97 | 13.8% |
About Steele Summers, FNP
Steele Summers, FNP is a Nurse Practitioner healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/21/2015. The National Provider Identifier (NPI) number assigned to this provider is 1437546041.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Steele Summers, FNP has received a total of $2,382 in payments from pharmaceutical and medical device companies, with $584.90 received in 2024. These payments were reported across 113 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($2,382).
As a Medicare-enrolled provider, Summers has provided services to 903 Medicare beneficiaries, totaling 1,455 services with total Medicare billing of $20,829. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Nurse Practitioner
- Location Indianapolis, IN
- Active Since 04/21/2015
- Last Updated 10/27/2023
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1437546041
Products in Payments
- DUPIXENT (Biological) $710.97
- TEZSPIRE (Biological) $316.88
- TRELEGY ELLIPTA (Drug) $266.15
- NUCALA (Biological) $224.14
- Xhance (Drug) $129.67
- FASENRA (Biological) $99.37
- Haegarda (Biological) $72.99
- PANZYGA (Biological) $62.43
- AYVAKIT (Drug) $61.93
- AirDuo Digihaler (Drug) $55.24
- OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug) $44.43
- Xembify (Biological) $43.85
- EOHILIA (Drug) $37.65
- AUVI-Q (Drug) $35.53
- CUVITRU (Biological) $31.97
- ORLADEYO (Drug) $19.18
- CUTAQUIG (Biological) $18.51
- RUCONEST (Biological) $18.11
- EUCRISA (Drug) $17.36
- XOLAIR (Drug) $15.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Indianapolis
Kristi Orbaugh, Np, NP
Nurse Practitioner — Payments: $1.1M
Nurse Practitioner $1.1M
Ms. Kacy Rogers, Np, NP
Nurse Practitioner — Payments: $42,515
Nurse Practitioner $42,515
Jennifer Maahs, Np, NP
Nurse Practitioner — Payments: $35,512
Nurse Practitioner $35,512
Brittany Savage, Agpcnp, AGPCNP
Nurse Practitioner — Payments: $34,832
Nurse Practitioner $34,832
Dr. Dawn Stepp, Np, NP
Nurse Practitioner — Payments: $30,745
Nurse Practitioner $30,745
Angela Pierce, Np, NP
Nurse Practitioner — Payments: $18,010
Nurse Practitioner $18,010